Reduction of myocardial inflammation with steroid is not necessarily associated with improvement in left ventricular function in patients with cardiac sarcoidosis: Predictors of functional improvement

International Journal of Cardiology

Volumn 176, Issue 2, 2014, Pages 522-525

  Takaya, Yoichi ^a   Kusano, Kengo Fukushima ^a   Nakamura, Kazufumi ^a   Kaji, Mitsumasa ^b   Shinya, Takayoshi ^a   Kanazawa, Susumu ^a   Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Okayama Diagnostic Imaging Center   (Japan)

Author keywords

Cardiac sarcoidosis; Imaging; Inflammation; Left ventricular function; Steroid

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GLUCOSE; HEPARIN; PREDNISONE; GLUCOCORTICOID;

ADULT; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART SCINTISCANNING; HISTOLOGY; HUMAN; HUMAN TISSUE; LETTER; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MYOCARDITIS; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS; AGED; CARDIOMYOPATHIES; CONVALESCENCE; DRUG EFFECTS; PHYSIOLOGY; PREDICTIVE VALUE; SCINTISCANNING; TREATMENT OUTCOME;

AGED; CARDIOMYOPATHIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; PREDICTIVE VALUE OF TESTS; PREDNISONE; RECOVERY OF FUNCTION; SARCOIDOSIS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84922400729     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.042     Document Type: Article

References (10)

1. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoidosis: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-11.
2. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-Term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.
3. Chiu CZ, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-Term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95: 143-6.
4. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005; 26: 1538-43.
5. Tadamura E, Yamamuro M, Kubo S, et al. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation 2006; 113: E771-3.
6. Hiraga H, Yuwai K, Hiroe M. Guideline for the diagnosis of cardiac sarcoidosis: Study report on diffuse pulmonary disease (in Japanese). Jpn Ministry of Health Welfare; 199323-4.
7. Tadamura E, Yamamuro M, Kubo S, et al. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation 1993; 113: E771-3.
8. Japanese Ministry of Health and Welfare. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord 2007; 27: 89-102.
9. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
10. Banba K, Kusano KF, Nakamura K, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4: 1292-9.